Study #2023-1065
Breast cancer-minimal/molecular residual disease detection and therapy monitoring in patients with early stage TNBC-Phase I (B-STRONGER-I)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
B-STRONGER-I molecular residual disease detection and therapy monitoring
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Breast
Study phase:
Not applicable
Physician name:
Carlos Barcenas
Department:
Breast Medical Oncology
For general questions about clinical trials:
1-855-493-3260
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.